This Morning's Technical Outlook on Medical Equipment Stocks -- Boston Scientific, Hologic, Intuitive Surgical, and Invacare

NEW YORK, March 28, 2018 /PRNewswire/ --

WallStEquities.com strives to bring the best free research to the investment community.  Today we are offering reports on BSX, HOLX, ISRG, and IVC which can be accessed for free by signing up to www.wallstequities.com/registration. WallStEquities.com revisits the Medical Appliances and Equipment industry, which includes companies that are engaged in the manufacture of medical instruments such as dental and surgical appliances. Four stocks have been selected for review this morning, and they are: Boston Scientific Corp. (NYSE: BSX), Hologic Inc. (NASDAQ: HOLX), Intuitive Surgical Inc. (NASDAQ: ISRG), and Invacare Corp. (NYSE: IVC). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Boston Scientific

Marlborough, Massachusetts headquartered Boston Scientific Corp.'s shares declined slightly by 0.81%, closing Tuesday's trading session at $27.03. The stock recorded a trading volume of 8.73 million shares, which was above its three months average volume of 8.09 million shares. The Company's shares have advanced 7.69% over the previous three months and 9.97% over the past year. The stock is trading 1.06% below its 50-day moving average. Additionally, shares of Boston Scientific, which develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide, have a Relative Strength Index (RSI) of 44.38. 

On March 21^st, 2018, Boston Scientific announced that it has entered into a definitive agreement to acquire NxThera, a privately-held company based in Maple Grove, Minnesota. The transaction consists of an upfront cash payment of $306 million and up to an additional $100 million in potential commercial milestone payments over the next four years. Get the full research report on BSX for free by clicking below at: www.wallstequities.com/registration/?symbol=BSX

Hologic

On Tuesday, shares in Marlborough, Massachusetts headquartered Hologic Inc. recorded a trading volume of 2.42 million shares. The stock declined slightly by 0.11%, ending the day at $37.63. The Company's shares are trading below their 50-day moving average by 6.05%. Furthermore, shares of Hologic, which develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the US, Europe, Asia/Pacific, and internationally, have an RSI of 36.20. 

On March 02^nd, 2018, Hologic and Royal Philips (PHG) announced a global partnership agreement to offer care professionals integrated solutions comprising diagnostic imaging modalities, advanced informatics, and services for screening, diagnosis, and treatment of women across the world. The collaboration combines Hologic's innovative mammography technologies and PHG's leading portfolio of ultrasound, MRI, CT, and X-ray systems, advanced informatics, and broad range of services. HOLX's complimentary research coverage is a few simple steps away at: www.wallstequities.com/registration/?symbol=HOLX

Intuitive Surgical

Sunnyvale, California headquartered Intuitive Surgical Inc.'s stock finished the day 2.38% lower at $405.22 with a total trading volume of 648,537 shares. The Company's shares have advanced 11.58% in the previous three months and 58.43% over the past year. The stock is trading above its 200-day moving average by 10.23%. Additionally, shares of Intuitive Surgical, which designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories, have an RSI of 38.91. 

On March 05^th, 2018, Intuitive Surgical has named Phil Bradshaw as its first General Manager in the UK and Ireland. Mr. Bradshaw will direct business strategy and operations for the Company in these countries. Register for your free research report on ISRG at: www.wallstequities.com/registration/?symbol=ISRG

Invacare

Shares in Elyria, Ohio headquartered Invacare Corp. ended yesterday's session 3.11% lower at $17.15. The stock recorded a trading volume of 559,974 shares, which was above its three months average volume of 397,880 shares. The Company's shares have advanced 0.88% over the previous three months and 45.34% over the past year. The stock is trading 9.03% above its 200-day moving average. Moreover, shares of Invacare, which together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide, have an RSI of 42.97. Wall St. Equities' downloadable research report on IVC available at: www.wallstequities.com/registration/?symbol=IVC

--

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

WSE has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: [email protected]
Phone number: +21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Wall St. Equities